| Azilva (azilsartan) / Takeda |
NCT04743063: Prospective Monitoring of Angiotensin Receptor Neprilysin Inhibitor in Older Adults With Heart Failure and Frailty |
|
|
| Active, not recruiting | N/A | 40000 | US | sacubitril/valsartan, Angiotensin II Receptor Blockers, azilsartan, candesartan, eprosartan, Irbesartan, losartan, Olmesartan, telmisartan, valsartan | Brigham and Women's Hospital | Heart Failure, Systolic, Frailty | 12/22 | 12/22 | | |
ChiCTR2300069431: Efficacy and Safety of Azilsartan plus Tripterygium and its Extracts for Hypertensive Nephropathy |
|
|
| Not yet recruiting | N/A | 192 | | Azilsartan + Placebo ;Azilsartan Plus Tripterygium and its extracts ;Irbesartan + Placebo | The Eighth Affiliated Hospital, Sun Yat-Sen University (Shenzhen Futian); The Eighth Affiliated Hospital, Sun Yat-Sen University (Shenzhen Futian), The Department of Cardiology, the Eighth Affiliated Hospital, Sun Yat-Sen University | Hypertensive Nephropathy | | | | |
NCT05107960: A Study of Azilsartan in Children From 6 to Less Than 16 Years Old With High Blood Pressure |
|
|
| Active, not recruiting | N/A | 5 | Japan | Azilsartan (TAK-536), AZILVA Tablets, AZILVA Granules 1% | Teva takeda | Hypertension | 08/24 | 08/24 | | |
NCT05753696: Azilsartan in Patients With Diabetic Kidney Disease and Hypertension |
|
|
| Recruiting | N/A | 106 | RoW | Azilsartan, Losartan | Second Affiliated Hospital, School of Medicine, Zhejiang University | Proteinuria, Kidney Dysfunction, Blood Pressure, Diabetic Kidney Disease | 10/24 | 12/24 | | |
ChiCTR2300073557: Study on the effect of azilsartan on the early index of renal injury |
|
|
| Not yet recruiting | N/A | 900 | | Azithartan 20mg/d ;Valsartan 80mg/d | Zhongshan Hospital, Fudan University; Zhongshan Hospital, Fudan University, Hengxin Funding | Hypertensive nephropathy | | | | |
ChiCTR2300070085: The effect of azisartan in combination with homocysteine descent therapy on left ventricular structure and function in patients with H-type hypertension and atrial fibrillation: a randomized, open-label, parallel controlled trial |
|
|
| Not yet recruiting | N/A | 196 | | Azilsartan 40 mg QD PO ;Candesartan 8 mg QD PO | The First Affiliated Hospital of Zhejiang University School of Medicine; The First Affiliated Hospital of Zhejiang University School of Medicine, Heng Xin Hypertension/Heart-Kidney Protection Medical Research Fund | H type Hypertension with atrial fibrillation | | | | |
ChiCTR2300071978: Duration of azilsartan for the treatment of nonscoop essential hypertension and long-term prognosis: a randomized controlled study |
|
|
| Not yet recruiting | N/A | 640 | | patients were instructed to take azilsartan in the morning (6:00-10:00), and the medication was adjusted by clinicians according to home blood pressure monitoring and follow-up blood pressure ;patients were instructed to take olmesartan cilexetil in the morning (6:00-10:00), and the medication was adjusted by clinicians according to home blood pressure monitoring and follow-up blood pressure ;patients are instructed to take azilsartan before bedtime (20:00-0:00), and the medication is adjusted by clinicians according to home blood pressure monitoring and follow-up blood pressure ;patients are instructed to take olmesartan cilexetil before bedtime (20:00-0:00), and the medication is adjusted by clinicians according to home blood pressure monitoring and follow-up blood pressure | Renmin Hospital of Wuhan University; Renmin Hospital of Wuhan University, Huaxia Cardiovascular Health Research Institute of Suzhou Industrial Park | hypertension | | | | |
